Accenture invested through its venture arm to back the artificial intelligence insurtech platform.
"Insurance companies today need digital tools that don’t just inform, but genuinely empower policyholders. Our investment in Rehuman’s AI-powered wallet goes beyond digital convenience – it transforms how insurers and brokers engage with policyholders, creating more seamless, personalized and meaningful experiences."
The Series A round was led by Singular with backing from Firstminute Capital and angel investors to fund international growth and AI research.
"Lupa saves me at least an hour per day. It absolutely changed my day-to-day veterinary life, ensuring I have far more time to spend treating my patients rather than working at my computer"
TwinPath Ventures led the pre-seed round to help accelerate regulatory clearance and clinical validation for the company's sepsis prediction software.
"I’ve lived through sepsis twice. I know how quickly stability becomes a crisis and how much an earlier insight can change the outcome. With VIOSync we’re giving clinicians a trusted, explainable way to predict risk before symptoms emerge, enabling faster decisions and ultimately saving lives. This funding is a strong validation of our mission and will help us accelerate both regulatory approvals and clinical adoption."
Bethnal Green Ventures led the pre-seed round, with participation from SFC Capital, SCE Freiraum Ventures, Cranfield University Seed Fund, and Benjamin Manwaring, to accelerate product development and scale pilot projects.